Two free slots available for the Paul Janssen Futurelab blended course Clinical Development! 

J&J Pharmaceuticals pays the course fee for 2 graduated biomedical professionals for their participation in the Paul Janssen Futurelab blended course Clinical Development. The free slots are available for biomedical professionals working at a biotech start-up that plans to start their First-in-Human (FIH) trial within 2 years. The online part of this course will start on March 14th 2022. If the course participant passes the online exam, he/she can also participate for free in the on-campus part that will take place in June 2023.
 
The Question-Based Clinical Development (QBCD) approach is central to the online part of the course. The QBCD approach is described in our Nature Biotechnology article of January 2020 (see below). More information about this and other courses can be found at https://lnkd.in/dBgFS73.
 
The candidate can apply for the free slot by sending an e-mail with a short motivation and CV to contact@pauljanssenfuturelab.eu. We apply the first-come-first-served principle.